Unlocking Clarity: Transform Complex Licensing Deals into Recognisable Revenue

Master IFRS 15 application for Pharmaceutical, MedTech, and Biotech licensing agreements. Learn from real-world case studies and gain the expertise to confidently handle milestone payments, tiered royalties, and multi-territory rights.

30+ Years Industry Experience
8 CPE Credits
20 Max Participants

Why This Workshop is Essential for Your Career

Pharmaceutical, MedTech, and Biotech licensing agreements are becoming increasingly complex. Traditional accounting methods struggle with milestone payments, tiered royalties, and multi-territory rights, creating compliance risks and uncertainty.

This intensive workshop is specifically designed for senior accounting and business development professionals at pharmaceutical companies. You will master IFRS 15 application through real-world case studies and gain the confidence to handle the most complex licensing scenarios.

Perfect for: Finance Directors, Controllers, Revenue Recognition Specialists, and Business Development professionals who need to stay ahead of evolving IFRS requirements.

Comprehensive 2-Day Curriculum

DAY ONE - February 11, 2026 (09:00-13:00) | Foundation & Contract Mastery
09:00 - 09:20
Welcome & Strategic Context
  • Participant introductions & experience sharing
  • Workshop objectives & expected outcomes
  • Industry landscape: Why IFRS 15 matters more than ever
  • Interactive poll: Current challenges in revenue recognition
09:20 - 09:35
Decoding Out-Licensing Deal Terms
  • Upfront payments & option fees: When and how to recognise
  • Milestone structures: Regulatory vs commercial milestones
  • Royalty arrangements: Sales-based and usage considerations
  • Complex deal components: Cost sharing, equity transfers, asset exchanges
09:35 - 10:00
IFRS 15 Core Principles Framework
  • Evolution from fragmented standards to unified approach
  • The five-step framework: Systematic application methodology
  • Quiz session: Testing core principles understanding
10:00 - 10:05
Customer vs Collaborator Relationships
  • Critical distinction: When IFRS 15 applies vs IFRS 11
  • Customer definition: Four key criteria assessment
10:05 - 11:45
Contracts - The Foundation of Revenue Recognition
  • Contract fundamentals & existence criteria
  • Contract terms & duration analysis
  • Contract costs & financial statement impact
  • Contract combinations, modifications & reassessments
12:00 - 13:00
Performance Obligations Identification
  • Distinct" criteria application
  • Clinical trial phases: Integrated vs separate obligations
  • Right-to-use vs right-to-access licensing
  • Over-time recognition methods
  • Workshop exercise with real scenarios
DAY TWO - February 12, 2026 (09:00-13:00) | Advanced Application & Future-Proofing
09:00 - 09:10
Day 1 Recap
09:10 - 10:30
Transaction Price Determination
  • Fixed vs variable consideration: Estimation techniques
  • Revenue constraint application
  • Significant financing components
  • Non-cash consideration valuation
10:45 - 11:05
Price Allocation & Revenue Recognition
  • Stand-alone selling price estimation methods
  • Control transfer assessment indicators
  • Royalty recognition rules and exemptions
  • Principal vs agent considerations
  • Decision trees for complex scenarios
11:05 - 11:20
Disclosure Requirements
11:20 - 11:35
Internal Controls & Documentation
11:55 - 13:00
Future Outlook & Action Planning
  • Emerging transaction types in digital health
  • IASB-FASB differences and implications
  • Implementation tips: Documentation and compliance
  • Your personal action plan development
  • Q&A session for specific challenges
  • Course Evaluation & Resources

What You Will Master

Day 1 Foundation Skills

  • Understand the complete out-licensing deal landscape and terminology
  • Apply the five-step IFRS 15 framework systematically
  • Distinguish between customer and collaborator relationships
  • Identify contracts that qualify for IFRS 15 treatment
  • Assess contract terms, duration, and modification requirements
  • Evaluate when multiple contracts should be combined
  • Apply the contract modification decision tree

Day 2 Advanced Application

  • Apply the two-part "distinct" criteria to pharmaceutical arrangements
  • Distinguish between right-to-use and right-to-access licensing structures
  • Estimate variable consideration using expected value and most likely amount methods
  • Apply revenue constraint principles to milestone payments
  • Calculate stand-alone selling prices using multiple estimation methods
  • Implement royalty recognition rules and sales-based exemptions
  • Distinguish between principal and agent relationships in distribution deals
  • Develop robust documentation processes for audit compliance

Designed for Senior Professionals

  • Finance Directors & Controllers in pharmaceutical companies
  • Revenue Recognition Specialists handling complex licensing deals
  • Business Development Managers structuring partnership agreements
  • Internal Auditors reviewing revenue recognition processes
  • Legal Counsel involved in licensing negotiations

Registration & Policies

Getting Started

  1. Complete the registration form with your details
  2. Review and agree to terms and conditions
  3. Add to cart and proceed to secure payment
  4. Receive immediate confirmation and course materials
Need assistance? Contact our team at sales@mioconsult.com for help with registration, purchase orders, or invoicing.

Flexible Transfer Policy

  • Option 1: Send a replacement participant to avoid cancellation charges
  • Option 2: Transfer your registration once at no cost (3 weeks prior to course start date)

What's Included

  • Zoom Interactive workshop with maximum 20 participants
  • Comprehensive digital course materials
  • 8 hours of CPE credits
  • Certificate of attendance
  • Post-workshop email support

Special Offers

Biotech Startups: €250 discount available.

Group Discounts: Available for teams of 3 or more participants.

Contact sales@mioconsult.com